Hepatitis C has been on the radar for long, and fortunately, new drugs and lines of treatment have evolved with time to relieve the patients of Hepatitis C with a healthy outlook towards the future by dodging the perilous disease.
Can Hepatitis C be cured? This isn’t a big question anymore, thanks to the researchers who have invented the treatment for Hepatitis C.
A cure is Possible Now
The treatment for Hepatitis C aims as completely eliminating the virus from your body. If your body doesn’t contain any signs of virus even after 6 months of stopping the medication, your treatment of Hepatitis C is considered successful.
Doctors and scientists began treating Hepatitis C back in 1990s with the help of interferon, a group of signaling proteins used for treating diseases caused by pathogens. Interferon improves and strengthens your immune system and your body’s ability to fight against the deadly virus by fortifying the defense system of the body.
Later, a drug called Ribavirin was given along with interferon to improve the treatment of Hepatitis C. This combination of drugs worked wonders and significantly improved the success rate of treatment from late 1980s mere 5% to the early 2000s’ staggering 50%.
Although, with time the doctors realized that the combination of interferon and ribavirin brings along a set of contraindications and side effects. The patients suffered fever, muscular pains, anxiety, nausea and sleeping disorders. Also, the line of treatment was too slow and it took the medicine long 48 weeks to start working and showing some positive results.
In 2011, two new drugs were approved by the FDA. These were telaprevir (Incivek) and boceprevir (Victrelis). These drugs helped in stopping the duplication of virus, the phenomenon by which the virus grows in the body.
Now, the doctors started prescribing Telaprevir and Boceprevir along with interferon and Ribavirin. All these drugs together increased the success rate to whopping 70 %, although, the side effects too drastically increased in the patients who took this combination, according to Ana Lok, MD.
A Revolution in the Treatment of Hepatitis C
Recently, in the year 2013 and 2014, four new drugs have been approved by the FDA for the treatment of Hepatitis C:
- Ledipasvir-sofosbuvir (Harvoni)
- Simeprevir (Olysio)
- Ombitasvir-paritaprevir-dasabuvir-ritonavir (Viekira Pak)
- Sofosbuvir (Sovaldi)
Treatment of Hepatitis C cannot be done under one rule of thumb. Depending on the type of virus and genotype the patient has, the prescription is made by the doctors. In the U.S., genotype 1 is the most commonly found Hepatitis C and Ledipasvir-sofosbuvir is a single pill treatment that can be given to the patients and there is no need to include ribavirin and interferon along with it.
Genotype 2 and 3 are also common in the U.S. but not as much as genotype 1. There are more types of hepatitis C viruses such as genotypes 4, genotype 5 and genotype 6 which are very rarely found among the patients in the U.S.
According to Lok, instead of the multi-pill treatment, the doctors as well as patients are very comfortable with this single pill treatment for Hepatitis C. giving the treatment to the patients without interferon has made the entire line of treatment exciting as well as relieving. Many such drugs are expected to roll out in a couple of years for providing better treatment to the patients.
Patients having chronic HCV genotype 1 are prescribed with Viekira Pak multi-pill. Viekira has a very high success rate at about 91 to 100%. This pill also helps in and works to ruling out the growth of Hepatitis C virus in the body. The doctors are prescribing Ombitasvir twice daily, Paritaprevir and Ritonavir tablets once daily each preferably in the mornings and one Dasabuvir tablet twice daily. This treatment goes on for 85 days, i.e., approximately 3 months.
Simeprevir along with interferon and Ribavirin is also a very successful combination for curing Hepatitis C. 80% of patients have recovered with this prescription too.
All you need to know about Hepatitis C
Many patients with different types of Hepatitis C are given Sofosbuvir. This drug can be given individually and there is absolutely no need to include interferon in the prescription. Sofosbuvir has a high cure rate of 90% and can be taken once daily for 3 months to start its mechanism. The FDA also approved Simeprevir (Olysio) in November 2014 to be used for genotype 1 patients along with sofosbuvir (Sovaldi). Again, there is no need to include ribavirin or interferon in the prescription.
For treating hepatitis C genotype 4, paritaprevir, ombitasvir, and ritonavir (Technivie) were approved in 2015. These can be used along with ribavirin. This treatment can prevent the use of interferon in treatment of Genotype 4 virus. The cure rate of this comobation is 100%, which is a great relief to doctors as well as patients. Daclatasvir (Daklinza) was also approved in 2015 for the treatment of genotype 3 hepitis C virus. Daclatasvir can be taken in combination with Sofosbuvir (Sovaldi) for up to 98% cure rate.
In the year 2016, Elbasvir and Grazoprevir (Zepatier) were approved for treating genotype 1and 4 with or without Ribavirin. Along with Harvoni and Viekira Pak, this drug can cure genotype 1 infection without interferon. With a cure rate of 94-97% for genotype and 100% for genotype 4, this is a wonder combination.
Hepatitis C Treatment Expenses
Treatment of Hepatitis C with new drugs can be a very expensive deal. Instead of spending a fortune on these medications, ask your health insurance company for programs you can benefit from and get financial aid from your insurer for your treatment.
We have put together is a complete turnkey package that will give everyone in need the ability to travel to India and receive their health changing medication. The trip is 7 days and all-inclusive except for lunch and dinner meals.
A lot of time and consideration went into finding the right medical facility and doctors. The best accommodations we could find and the transportation guides to make the clients feel extremely secure.
The price for the whole package is as follows,
$5,200 for one person.
Or $6,400 to include a companion.
We will also offer financing assistance if needed. We welcome any additional suggestions you might have. Also, we will encourage all of the clients to participate with the Imperial Medical College in London to achieve the needed information for assurance of their generic program.
WE’RE HERE TO HELP
Call +1-928-328-8909 to get helpful information, a Hep C guide, and facts about managing Hep C.